Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume 37, Issue 4, Pages 519-529
Publisher
Springer Nature
Online
2016-02-29
DOI
10.1038/aps.2015.153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background
- (2016) Zhimin Ye et al. CANCER LETTERS
- Update on Survival in Osteosarcoma
- (2016) Megan E. Anderson ORTHOPEDIC CLINICS OF NORTH AMERICA
- P53-dependent miRNAs mediate nitric oxide-induced apoptosis in colonic carcinogenesis
- (2015) Weiwei Li et al. FREE RADICAL BIOLOGY AND MEDICINE
- The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues
- (2015) Liguang Wang et al. GENE
- miR-34 and p53: New Insights into a Complex Functional Relationship
- (2015) Francisco Navarro et al. PLoS One
- Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness
- (2015) Helge Siemens et al. Oncotarget
- mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma
- (2014) Wesley K. Utomo et al. CANCER LETTERS
- Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis
- (2014) Hamidreza Maroof et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Systematic identification of signaling pathways with potential to confer anticancer drug resistance
- (2014) C. A. Martz et al. Science Signaling
- Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma
- (2014) Zorica Milosevic et al. Translational Research
- The p53/miR-34 axis in development and disease
- (2014) M. Rokavec et al. Journal of Molecular Cell Biology
- MTOR inhibition attenuates DNA damage and apoptosis through autophagy-mediated suppression of CREB1
- (2013) Ying Wang et al. Autophagy
- Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis
- (2013) M. Janaki Ramaiah et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Circadian Regulation of mTOR by the Ubiquitin Pathway in Renal Cell Carcinoma
- (2013) Hiroyuki Okazaki et al. CANCER RESEARCH
- A phase I study of decitabine and rapamycin in relapsed/refractory AML
- (2013) Jane L. Liesveld et al. LEUKEMIA RESEARCH
- TP53-independent Function of miR-34a via HDAC1 and p21CIP1/WAF1
- (2013) Jane Zhao et al. MOLECULAR THERAPY
- miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells
- (2013) Ke Jin et al. TUMOR BIOLOGY
- MiR-34 and SNAIL: Another double-negative feedback loop controlling cellular plasticity/EMT governed by p53
- (2012) Thomas Brabletz CELL CYCLE
- Phase I Study of the Antiangiogenic Antibody Bevacizumab and the mTOR/Hypoxia-Inducible Factor Inhibitor Temsirolimus Combined with Liposomal Doxorubicin: Tolerance and Biological Activity
- (2012) J. Moroney et al. CLINICAL CANCER RESEARCH
- Targeting CSC-Related miRNAs for Cancer Therapy by Natural Agents
- (2012) Bin Bao et al. CURRENT DRUG TARGETS
- PAK1-dependent MAPK pathway activation is required for colorectal cancer cell proliferation
- (2012) Haitao Qing et al. TUMOR BIOLOGY
- Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells
- (2012) G M A Ajabnoor et al. Cell Death & Disease
- miRNA signature associated with outcome of gastric cancer patients following chemotherapy
- (2011) Chang Hee Kim et al. BMC Medical Genomics
- mTORC1 activity as a determinant of cancer risk – Rationalizing the cancer-preventive effects of adiponectin, metformin, rapamycin, and low-protein vegan diets
- (2011) Mark F. McCarty MEDICAL HYPOTHESES
- Regulation of Myc by miR-34c: A mechanism to prevent genomic instability?
- (2010) Ian Cannell et al. CELL CYCLE
- Rapamycin Pharmacokinetic and Pharmacodynamic Relationships in Osteosarcoma: A Comparative Oncology Study in Dogs
- (2010) Melissa C. Paoloni et al. PLoS One
- Targeting mammalian target of rapamycin to both downregulate and disable the P-glycoprotein pump in multidrug-resistant B-cell lymphoma cell lines
- (2009) Iliodora V. Pop et al. LEUKEMIA & LYMPHOMA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started